Consider Ingrezza When Treatment Is Needed for Tardive Dyskinesia
The approval of Ingrezza (in-GREH-zah, valbenazine) will raise questions about how to treat tardive dyskinesia.
Up to 30% of patients on long-term antipsychotics develop tardive dyskinesia. It's usually associated with higher doses, longer duration, and higher-potency typical antipsychotics, such as haloperidol.
But it can also occur with atypical antipsychotics, such as risperidone...and other dopamine blockers, such as metoclopramide.